APPLICATION
ANDA075574
TYPE
ANDA
ORIGINAL APPROVAL
2000-10-18
LATEST ACTION
2024-10-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 8MG BASE · TABLET · ORAL
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 2MG BASE · TABLET · ORAL
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 4MG BASE · TABLET · ORAL
DOXAZOSIN MESYLATEDiscontinued
DOXAZOSIN MESYLATE EQ 1MG BASE · TABLET · ORAL
Approval history
2024-10-31Labeling · Supplement 15 · standardAP
2024-10-31Labeling · Supplement 16 · standardAP
2004-02-04Labeling · Supplement 5AP
2002-10-22Labeling · Supplement 3AP
2001-11-02Manufacturing (CMC) · Supplement 2AP
2001-06-21Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.